Cellid Cuts Stock Option Exercise Price to KRW 9,826 Following Capital Increase

• Cellid’s Oct. 19, 2026, correction raises its stock option grant to 23,198 common shares from 22,546 following a capital increase.
• The exercise price falls to KRW 9,826 from KRW 10,111.
• Total stock options granted rise to 191,435 common shares from 186,234.
• The options, granted Feb. 25, 2020, are exercisable from Feb. 26, 2023, through Feb. 25, 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellid Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261019000095), on October 19, 2026, and is solely responsible for the information contained therein.